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Abstract
Stem cells have revolutionized research and applications for
biomedical sciences. In combination with gene therapy as well as
regenerative medicine, stem cells have led to several breakthrough
technologies. Utilizing these advances, coupled with rDNA
techniques, adult stem cells can be re-engineered to behave like
embryonic stem cells. These induced Pluripotent Stem cells
(iPSCs) can be introduced into the body in order to repair and
rectify the underlying issues

Fig 1. Induced
pluripotent adult stem
cells (iPSCs) and
differentiation.
https://sites.google.co
m/site/stemcellresearc
hdebate/argument/adv
antages-anddisadvantages-ofadult-stem-cells

Discussion

Introduction
Examples

At the same time that researchers are improving the efficacy of
stem-cell therapy, gene therapy offers the ability to replace mutated
genes with healthy copies, or insert genes that have been designed
to boost the production of vital proteins. Brought together, these
two technologies have enormous potential to both correct
pathological genetic mutations, and incorporate those corrections
into new cell populations in the body

Fig 2. Use of iPSCs
for localized
delivery and repair
of damaged Retinal
photoreceptors
(RPE)
https://www.nejm.or
g/doi/full/10.1056/n
ejmra1716145

Novelty of Work
What makes this work so unique is by using the natural ability of
stem cells to differentiate based on their environment you can have
targeted Gene therapies and ensure that at least some of the cells
in that area have the correct genetic material

Methodology
The methodology for all of these techniques is very similar. First
stem cells are either gathered from the host and created via
chemical rDNA induction. Those stem cells are then genetically
transformed and selected for uptake of the new genetic change.
Once these changes have been made in a petri dish (Ex Vivio) the
altered stem cells are inserted or injected into the area where repair
is needed. There the stem cells differentiate into the correct form
based on signaling from their environment, but because they have
the new corrected gene they will survive and propagate the
corrected material

Fig 3. A Gene correction
is inserted into iPSCs.
The modified iPSCs are
then administered where
they fix the improper
gene expression
https://www.nejm.org/doi
/full/10.1056/nejmra171
6145
Figure 4. Proposed
mechanisms for MSC
action in patients with
severe COVID-19.
https://www.nature.com/
articles/s41392-02100754-6

The use of induced pluripotent stem cells with gene therapy
has the potential to do what either one would lack the ability
to do on its own. While Gene therapies have the potential to
fix some of the most debilitating conditions because of their
lack of specificity and the possibility of creating an immune
response they have limited viability and have had halting
research. iPSCs have incredible therapeutic and
regenerative qualities, but because they use that patient's
own cells any problems that are genetic will just reestablish
themselves. By marrying the specificity and immunocompatible nature of stem cells with the targeted genetic
treatments personalized medicine will take a huge leap
forward.

Conclusion
Because the gene editing happens outside the patient, there is
an opportunity to filter out any aberrant stem cells before they
are transplanted back into the patient. But that doesn’t
guarantee that all of the transplanted cells will be
perfect. Though genome editing in human pluripotent stem cells
has historically been very difficult due to the inefficiency the
development of custom-engineered endonucleases to precisely
target DNA DSBs substantially increased the efficiency of HDRbased gene editing in human stem cells
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